CD8A and neoplasm: Here, we compare the conjugation of the immunodominant CD8+ T cell epitope of OVA (SIINFEKL) to the whole protein, OVA, to verify whether a single peptide is sufficient to induce long-term CD8+ T cell responses and to inhibit tumor outgrowth.